IMA901 in Advanced Renal Cell Carcinoma Patients With Measurable Disease (IMA901-202)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00523159
Recruitment Status : Completed
First Posted : August 31, 2007
Last Update Posted : July 10, 2012
Information provided by (Responsible Party):
immatics Biotechnologies GmbH

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2009
  Actual Study Completion Date : August 2009